2012
DOI: 10.1161/circulationaha.112.109389
|View full text |Cite
|
Sign up to set email alerts
|

Dissecting the Role of G-Protein–Coupled Receptor Kinase 2 for Excitation-Contraction Coupling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Among candidate molecules, the sarcoplasmic reticulum Ca 2+ -ATPase 2a (SERCA2a) is one that regulates intracellular Ca 2+ levels, and, thereby, pulmonary smooth muscle cell proliferation and vasoconstriction, and is known to be downregulated in remodeled pulmonary blood vessels isolated from patients with PAH as compared to patients with other forms of lung disease. 44 As activation of α-adrenergic signaling increases intracellular Ca 2+ levels in PAH, restoring SERCA2a expression and activity is one method to decrease intracellular Ca 2+ levels and modify pulmonary vascular remodeling (Figure 4). In monocrotaline-PAH rats with documented downregulation of SERCA2a in the pulmonary arterioles and RV, intratracheal aerosolized gene transfer of aerosolized adeno-associated virus serotype 1 (AAV1) carrying SERCA2a resulted in efficient transduction of the pulmonary vasculature leading to a reduction in pulmonary artery pressures, vascular remodeling, and RV hypertrophy.…”
Section: Interventions That Target the Sympathetic Nervous System In Pahmentioning
confidence: 99%
“…Among candidate molecules, the sarcoplasmic reticulum Ca 2+ -ATPase 2a (SERCA2a) is one that regulates intracellular Ca 2+ levels, and, thereby, pulmonary smooth muscle cell proliferation and vasoconstriction, and is known to be downregulated in remodeled pulmonary blood vessels isolated from patients with PAH as compared to patients with other forms of lung disease. 44 As activation of α-adrenergic signaling increases intracellular Ca 2+ levels in PAH, restoring SERCA2a expression and activity is one method to decrease intracellular Ca 2+ levels and modify pulmonary vascular remodeling (Figure 4). In monocrotaline-PAH rats with documented downregulation of SERCA2a in the pulmonary arterioles and RV, intratracheal aerosolized gene transfer of aerosolized adeno-associated virus serotype 1 (AAV1) carrying SERCA2a resulted in efficient transduction of the pulmonary vasculature leading to a reduction in pulmonary artery pressures, vascular remodeling, and RV hypertrophy.…”
Section: Interventions That Target the Sympathetic Nervous System In Pahmentioning
confidence: 99%